Form 4: Sanara MedTech Officer's Routine Stock Vesting Tax

Sentiment:

Insider Transaction Report


A Sanara MedTech officer had shares withheld to cover tax obligations from restricted stock vesting, a routine transaction.

Summary

  • Michael D. McNeil, Chief Accounting and Chief Administrative Officer of Sanara MedTech Inc. (SMTI), reported a transaction on August 19, 2025.
  • The transaction involved the disposition of 2,324 shares of common stock.
  • These shares were withheld by Sanara MedTech Inc. to satisfy tax withholding obligations.
  • The withholding was in connection with the accelerated vesting of 9,543 shares of restricted stock previously granted to Mr. McNeil.
  • The per-share value assigned to the withheld shares was $30.86, reflecting the price on the Nasdaq Capital Market on the vesting date.
  • No shares were issued or sold in this transaction; it was solely for tax purposes.
  • Following this transaction, Mr. McNeil beneficially owns 28,587 shares of common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction (tax withholding on stock vesting) that is neutral in sentiment. It reflects standard compensation practices and tax compliance.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it reports a past transaction.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is common across all publicly traded companies when restricted stock units or similar equity awards vest.

Related Party Transactions

  • The transaction involves shares withheld by the Issuer (Sanara MedTech Inc.) from an officer (Michael D. McNeil) to cover tax obligations related to previously granted restricted stock, which is a common form of related-party compensation.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-dilutive transaction for tax purposes. It reflects standard executive compensation practices.
  • Employees: No direct impact on general employees.

Key Dates

DateDescription
08/19/2025Date of transaction for tax withholding related to restricted stock vesting.

Keywords

Sanara MedTech, SMTI, SEC Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Restricted Stock, Officer Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.